Table 1 Clinical criteria for patient selection
Cohort | Inclusion Criteria (All Within 3 Months of a Shoulder US) |
|---|---|
Obese withT2DM (n = 31) | -Documented diagnosis of T2DM -HbA1c level > 6.5% (48 mmol/mol) -Prescribed at least 1 T2DM medication -BMI ≥ 30 kg/m2 |
Non-obese with T2DM (n = 31) | -Documented diagnosis of T2DM -HbA1c level > 6.5% (48 mmol/mol) -Prescribed at least 1 T2DM medication -BMI < 30 kg/m2 |
Obese without T2DM (n = 31) | -Never diagnosed with T2DM or prediabetes/IGT -HbA1c level < 5.7% (39 mmol/mol) or none available -Never prescribed T2DM medication -BMI ≥ 30 kg/m2 |
Non-obese without T2DM (n = 31) | -Never diagnosed with T2DM or prediabetes/IGT -HbA1c level < 5.7% (39 mmol/mol) or none available -Never prescribed T2DM medication -BMI < 30 kg/m2 |